Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/43016
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | Wolfs, Esther | - |
dc.contributor.advisor | Lambrichts, Ivo | - |
dc.contributor.advisor | Van Den Bosch, Ludo | - |
dc.contributor.author | LIBBERECHT, Karen | - |
dc.date.accessioned | 2024-05-29T09:28:24Z | - |
dc.date.available | 2024-05-29T09:28:24Z | - |
dc.date.issued | 2024 | - |
dc.date.submitted | 2024-05-13T09:21:05Z | - |
dc.identifier.uri | http://hdl.handle.net/1942/43016 | - |
dc.description.abstract | This work focuses on advancing fundamental research in CMT1A. Addressing the lack of available treatments for this disease, this thesis has three primary aims: developing novel human-based in vitro models, unraveling the underlying mechanisms of PMP22 gene overexpression in Schwann cells at a lysosomal level, and exploring the potential of rebalancing cAMP levels to alleviate the CMT1A phenotype (Fig. 1-4). | - |
dc.language.iso | en | - |
dc.title | Unraveling CMT1A: Models, Mechanisms, and Therapeutic Approaches | - |
dc.type | Theses and Dissertations | - |
local.bibliographicCitation.jcat | T1 | - |
local.type.specified | Phd thesis | - |
local.provider.type | - | |
local.uhasselt.international | no | - |
item.fullcitation | LIBBERECHT, Karen (2024) Unraveling CMT1A: Models, Mechanisms, and Therapeutic Approaches. | - |
item.embargoEndDate | 2029-05-29 | - |
item.contributor | LIBBERECHT, Karen | - |
item.fulltext | With Fulltext | - |
item.accessRights | Embargoed Access | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Doctoraat FINAAL - Karen LIBBERECHT versie2 met cover.pdf Until 2029-05-29 | Published version | 3.98 MB | Adobe PDF | View/Open Request a copy |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.